---
figid: PMC4480706__oncotarget-06-7644-g008
figtitle: HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC4480706
filename: oncotarget-06-7644-g008.jpg
figlink: /pmc/articles/PMC4480706/figure/F8/
number: F8
caption: HDAC9 interacts with TAZ, enhances the expression of TAZ, and then phosphorylates
  EGFR. The phosphorylation of EGFR activates PI3K and ERK signaling pathways, increases
  the expression of cyclin E and CDK2, accelerates cell cycle progression, and then
  promotes cell proliferation and tumor progression in GBM.
papertitle: HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation.
reftext: Rui Yang, et al. Oncotarget. 2015 Apr 10;6(10):7644-7656.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.950501
figid_alias: PMC4480706__F8
figtype: Figure
redirect_from: /figures/PMC4480706__F8
ndex: 9367af85-dea4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4480706__oncotarget-06-7644-g008.html
  '@type': Dataset
  description: HDAC9 interacts with TAZ, enhances the expression of TAZ, and then
    phosphorylates EGFR. The phosphorylation of EGFR activates PI3K and ERK signaling
    pathways, increases the expression of cyclin E and CDK2, accelerates cell cycle
    progression, and then promotes cell proliferation and tumor progression in GBM.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Taz
  - Dis3
  - Egfr
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Erk7
  - rl
  - Cdk2
  - CycE
  - cyc
  - HDAC9
  - TAFAZZIN
  - WWTR1
  - EGFR
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - EPHB2
  - MAPK1
  - MAPK3
  - CDK2
  - CCNE1
  - CCNE2
---
